Updates on recent agreements, acquisitions and investments in the pharmaceutical industry.
On March 23, 2010, President Barack Obama signed into law the new healthcare reform legislation titled the Affordable Health Care for America Act.
America’s pharmaceutical research and biotechnology companies sent more than $25 million in medicines, medical supplies and cash to Haitian relief efforts after a catostrophic earthquake.
CSL Behring has received Food and Drug Administration approval for its Hizentra immune globulin subcutaneous (human) 20% liquid for treating patients diagnosed with primary immunodeficiency.